US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Dementia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Dementia. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Dementia. ...  |  read more...
USD 2,000
Fibromyalgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Fibromyalgia. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Fibromyalgia. ...  |  read more...
USD 2,000
Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Glioblastoma Multiforme (GBM). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Glioma. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Glioma. ...  |  read more...
USD 2,000
Medulloblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Medulloblastoma. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Medulloblastoma. ...  |  read more...
USD 2,000
Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Metastatic Brain Tumor. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Narcolepsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Narcolepsy. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Narcolepsy. ...  |  read more...
USD 2,000
Global Depression Therapy & Treatment Market – Depression drugs and devices, Anxiety Disorders,  SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Psychoanalysis, Cognitive Behavior, Psychodynamic, Electroconvulsive Pipeline Analysis,
1/16/2015 | published by: Occams Business Research & Consultancy
... Share, Growth, Trends And Forecast 2014 – 2020 Depression is a state of emotion that affects thoughts, actions and often, sleeping patterns of affected individual. Depression affects behavior in terms of loss of appetite, being ...  |  read more...
USD 4,000
Virtual Reality in Healthcare Market, Markets for Remote Surgery, 3D Modeling, Pain Distraction and Other Applications) Global Industry Analysis, Size, Share, Demand, Future, Growth, Trends, Opportunities (Psychology, Radiology, Oncology) Segmentation And
2/6/2015 | published by: Occams Business Research & Consultancy
... Reality technology is a computer-simulated environment that can recreate sensory experiences and stimulate presence in locations that are from the real world or may be from an imagined world. It has generated tremendous excitement in ...  |  read more...
USD 2,800
Brain Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... primary brain tumors are relatively rare, the chances of survival for patients with the disease are very low, even with the best treatment options currently available. There are today 224 companies plus partners developing 276 ...  |  read more...
USD 6,746
Assistive Technology for People with Dementia
11/26/2014 | published by: Emerald Group Publishing Limited
... address a small sample of various everyday life needs – use of information and communication technology, reminders on carrying out tasks, being safe and able to communicate with carers when out of the home, and, ...  |  read more...
USD 199
Seizures-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Seizures. This report provides information on the therapeutic development based on the Seizures dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
Intraoperative Neuromonitoring Market in the US 2015-2019
11/26/2014 | published by: TechNavio - Infiniti Research Ltd.
... be used in various surgical procedures including neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, cardiac surgery, genitourinary surgery, interventional radiological procedures, and other general surgeries. It plays a vital role in surgery to provide immediate ...  |  read more...
USD 2,500
Optical Imaging Market by Technique (Optical Coherence Tomography, Hyperspectral Imaging, Photoacoustic Tomography), Product (Imaging System, Imaging software) & by Application (Ophthalmology, Neurology, Oncology, Cardiology) - Global Forecasts to 2019
10/17/2014 | published by: MarketsandMarkets
... optical imaging market has grown, primarily due to the widening applications of optical imaging techniques, the increased demand for safer and noninvasive imaging modalities, and a rising need to minimize the use of radiation in ...  |  read more...
USD 4,650
Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Cerebral Infarction (Brain Infarction), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Treatment Resistant Depression - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... information on the therapeutic development for Treatment Resistant Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Nicotine Addiction - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Nicotine Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Recurrent Glioblastoma Multiforme (GBM), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Depression Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) - Global Forecast to 2019
12/16/2014 | published by: MarketsandMarkets
... the plasma fractionation market witnessed tremendous growth, primarily due to the growth in aging population, increasing number of hemophilic patients, rising use of IVIg, and high prevalence of chronic disorders across the globe. In this ...  |  read more...
USD 4,650
Mental Illness Drugs Markets in China
12/1/2014 | published by: Asia Market Information & Development Company
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines ...  |  read more...
USD 4,000
Central Nervous System Disorder Drugs Markets in China
12/1/2014 | published by: Asia Market Information & Development Company
... will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. ...  |  read more...
USD 4,000
Tourette Syndrome-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Tourette Syndrome. This report provides information on the therapeutic development based on the Tourette Syndrome dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Depression - Pipeline Review, H2 2014
10/31/2014 | published by: Global Markets Direct
... Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Memory Impairment - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic development for Memory Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
1  2    4    6  7  8  9  10